Genzyme General News

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia Genzyme Corporation and Isis Pharmaceuticals, Inc.

Genzyme, a Sanofi company , and Isis Pharmaceuticals Inc. , announced today that the U.S. Food and Drug Administration has accepted for filing the New Drug Application for KYNAMROa for the treatment of patients with homozygous familial hypercholesterolemia .

AGE: 18 HOMETOWN: Sterling PARENTS: Ganeshan Venkataraman and Rekha Krishnamurthy HONOR AND AWARDS: 2011 Genzyme Award; NOAA Pulse of the Planet Award; MIT Lemelson Public Service Award; Elizabeth Haskins Mathematics Contest Award.

Sanofi's key business strengths include its critical mass in research and development and marketing, which we view as key success factors for the pharmaceutical industry.

Boston, May 17, 2012 The Boston Globe unveiled today its annual Globe 100 list ranking the best-performing public companies in Massachusetts, and Momenta Pharmaceuticals claims the number one spot.

The company's generic version of the anti-blood-clotting drug Lovenox - priced about 30 percent cheaper than the brand-name drug made by French pharmaceutical giant Sanofi SA - helped boost Momenta's revenues by 142 percent to $283 million last year, while profits zoomed 383 percent to $180 million.

McDonald's Corp. affirms a report in China Daily that says it increased the four different products by 1 yuan , at the end of April, marking the second price bump so far this year.

Billionaire activist investor Carl Icahn has made a fortune off of targeting declining biotech companies.

In part I of this series, Neostem and Aastrom stood out in a field of 6 stem cell biotechs with their advancing trials, recent financing, manufacturing capabilities and/or current revenue generation .

Pharmaceutical research, development, and marketing are not limited by national borders.

Thank you for your interest in the Supv Quality Control. To begin the application process, please enter your email address.

CAMBRIDGE, Mass.-- --May 3, 2012 - Genzyme , a Sanofi company , announced today that the Food and Drug Administration and the European Medicines Agency have approved a second suite for filling and finishing product at its Waterford, Ireland manufacturing plant.

Most European stock markets rose on Thursday, with banks and drug makers in the lead, as the European Central Bank kept its key lending rate unchanged and as Spain successfully sold more than 2.5 billion euros of bonds.

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia Pfizer Inc.

U.S. drug regulators gave the nod on Tuesday to Protalix Biotherapeutics Inc and Pfizer Inc's experimental biotech drug for a form of the rare genetic disease Gaucher.

Thank you for your interest in the Quality Control Scientist I. To begin the application process, please enter your email address.

April 29--Trading in shares of Protalix Biotherapeutics Inc. has been heavy in recent weeks, ahead of a decision by US Food and Drug Administration whether to approve the company's treatment for Gaucher's disease Uplyso.

Secretary of Housing and Economic Development Greg Bialecki along with MassEcon Chairman Fred Mulligan and Executive Director Susan Houston welcome new business to the Bay State.